Sign up to save your podcasts
Or
Share Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure
NNT of 20 to prevent 1 hospitalization at 16 months of follow up
They composite outcome was driven by decrease hospitalizations NOT death
https://www.nejm.org/doi/full/10.1056/NEJMoa2022190
View all episodes
By Questioning Medicine
4.9
7474 ratings
NNT of 20 to prevent 1 hospitalization at 16 months of follow up
They composite outcome was driven by decrease hospitalizations NOT death
https://www.nejm.org/doi/full/10.1056/NEJMoa2022190
More shows like Questioning Medicine
View all
Global News Podcast
7,683 Listeners
Sawbones: A Marital Tour of Misguided Medicine
14,825 Listeners
JAMA Editors' Summary
137 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
497 Listeners
Frankly Speaking About Family Medicine
259 Listeners
White Coat Investor Podcast
2,441 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Up First from NPR
56,692 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
The Matt Walsh Show
28,467 Listeners
Consider This from NPR
6,413 Listeners
The Curious Clinicians
370 Listeners
Huberman Lab
29,219 Listeners
The Checkup with Doctor Mike
1,314 Listeners